These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 10848607)

  • 1. Assembly of a functional beta interferon enhanceosome is dependent on ATF-2-c-jun heterodimer orientation.
    Falvo JV; Parekh BS; Lin CH; Fraenkel E; Maniatis T
    Mol Cell Biol; 2000 Jul; 20(13):4814-25. PubMed ID: 10848607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of ATF-2/c-Jun and IRF-3 bound to the interferon-beta enhancer.
    Panne D; Maniatis T; Harrison SC
    EMBO J; 2004 Nov; 23(22):4384-93. PubMed ID: 15510218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assembling the human IFN-beta enhanceosome in solution.
    Dragan AI; Carrillo R; Gerasimova TI; Privalov PL
    J Mol Biol; 2008 Dec; 384(2):335-48. PubMed ID: 18823997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome.
    Yie J; Merika M; Munshi N; Chen G; Thanos D
    EMBO J; 1999 Jun; 18(11):3074-89. PubMed ID: 10357819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo.
    Wathelet MG; Lin CH; Parekh BS; Ronco LV; Howley PM; Maniatis T
    Mol Cell; 1998 Mar; 1(4):507-18. PubMed ID: 9660935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer.
    De Cesare D; Vallone D; Caracciolo A; Sassone-Corsi P; Nerlov C; Verde P
    Oncogene; 1995 Jul; 11(2):365-76. PubMed ID: 7624151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability and DNA-binding ability of the bZIP dimers formed by the ATF-2 and c-Jun transcription factors.
    Carrillo RJ; Dragan AI; Privalov PL
    J Mol Biol; 2010 Feb; 396(2):431-40. PubMed ID: 19944700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The high mobility group protein HMG I(Y) can stimulate or inhibit DNA binding of distinct transcription factor ATF-2 isoforms.
    Du W; Maniatis T
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11318-22. PubMed ID: 7972056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription.
    Merika M; Williams AJ; Chen G; Collins T; Thanos D
    Mol Cell; 1998 Jan; 1(2):277-87. PubMed ID: 9659924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome.
    Kim TK; Maniatis T
    Mol Cell; 1997 Dec; 1(1):119-29. PubMed ID: 9659909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of IRF-3 bound to the PRDIII-I regulatory element of the human interferon-beta enhancer.
    Escalante CR; Nistal-Villán E; Shen L; García-Sastre A; Aggarwal AK
    Mol Cell; 2007 Jun; 26(5):703-16. PubMed ID: 17560375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemia and reperfusion enhance ATF-2 and c-Jun binding to cAMP response elements and to an AP-1 binding site from the c-jun promoter.
    Morooka H; Bonventre JV; Pombo CM; Kyriakis JM; Force T
    J Biol Chem; 1995 Dec; 270(50):30084-92. PubMed ID: 8530413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proximal regulatory element of the interferon-gamma promoter mediates selective expression in T cells.
    Penix LA; Sweetser MT; Weaver WM; Hoeffler JP; Kerppola TK; Wilson CB
    J Biol Chem; 1996 Dec; 271(50):31964-72. PubMed ID: 8943243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of intrinsic DNA bends in the IFN beta gene enhancer by transcription factors and the architectural protein HMG I(Y).
    Falvo JV; Thanos D; Maniatis T
    Cell; 1995 Dec; 83(7):1101-11. PubMed ID: 8548798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B lymphocyte-induced maturation protein (Blimp)-1, IFN regulatory factor (IRF)-1, and IRF-2 can bind to the same regulatory sites.
    Kuo TC; Calame KL
    J Immunol; 2004 Nov; 173(9):5556-63. PubMed ID: 15494505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric recognition of nonconsensus AP-1 sites by Fos-Jun and Jun-Jun influences transcriptional cooperativity with NFAT1.
    Ramirez-Carrozzi V; Kerppola T
    Mol Cell Biol; 2003 Mar; 23(5):1737-49. PubMed ID: 12588992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression.
    Lefort S; Soucy-Faulkner A; Grandvaux N; Flamand L
    J Virol; 2007 Oct; 81(20):10950-60. PubMed ID: 17652396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of the orientation of Fos-Jun binding and the transcriptional cooperativity of Fos-Jun-NFAT1 complexes.
    Ramirez-Carrozzi VR; Kerppola TK
    J Biol Chem; 2001 Jun; 276(24):21797-808. PubMed ID: 11259418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A distal regulatory region is required for constitutive and IFN-beta-induced expression of murine TLR9 gene.
    Guo Z; Garg S; Hill KM; Jayashankar L; Mooney MR; Hoelscher M; Katz JM; Boss JM; Sambhara S
    J Immunol; 2005 Dec; 175(11):7407-18. PubMed ID: 16301648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.